Banco Santander (BSBR) Forms $11.47 Double Top; Icad (ICAD) Shorts Raised By 18.9%

iCAD, Inc. (NASDAQ:ICAD) Logo

Icad Inc (NASDAQ:ICAD) had an increase of 18.9% in short interest. ICAD’s SI was 56,000 shares in April as released by FINRA. Its up 18.9% from 47,100 shares previously. With 29,600 avg volume, 2 days are for Icad Inc (NASDAQ:ICAD)’s short sellers to cover ICAD’s short positions. The SI to Icad Inc’s float is 0.44%. The stock decreased 1.04% or $0.03 during the last trading session, reaching $3.22. About 46,633 shares traded or 37.74% up from the average. iCAD, Inc. (NASDAQ:ICAD) has declined 37.53% since April 8, 2017 and is downtrending. It has underperformed by 49.08% the S&P500.

Banco Santander (BSBR) formed double top with $12.39 target or 8.00% above today’s $11.47 share price. Banco Santander (BSBR) has $43.83B valuation. The stock decreased 3.37% or $0.4 during the last trading session, reaching $11.47. About 2.08 million shares traded or 58.80% up from the average. Banco Santander (NYSE:Brasil S) has 0.00% since April 8, 2017 and is . It has underperformed by 11.55% the S&P500.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. The company has market cap of $53.46 million. It operates through two divisions, Cancer Detection and Cancer Therapy. It currently has negative earnings. The firm provides electronic brachytherapy products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy.